These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25911818)

  • 1. [Discovery of potential nicotinic acid receptor agonists from Chinese herbal medicines based on molecular simulation].
    Jiang LD; He YS; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4653-7. PubMed ID: 25911818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
    Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
    Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on lipid-lowering traditional Chinese medicines based on pharmacophore technology and patent retrieval].
    Huo XQ; He YS; Qiao LS; Sun ZY; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4839-43. PubMed ID: 25898588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.
    Shen HC
    Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
    Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of selective farnesoid X receptor agonists for the treatment of hyperlipidemia from traditional Chinese medicine based on virtual screening and in vitro validation.
    Chen X; Lu F; Luo G; Ren Y; Ma J; Zhang Y
    J Biomol Struct Dyn; 2020 Sep; 38(15):4461-4470. PubMed ID: 31842697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.
    van Veldhoven JP; Liu R; Thee SA; Wouters Y; Verhoork SJ; Mooiman C; Louvel J; IJzerman AP
    Bioorg Med Chem; 2015 Jul; 23(14):4013-25. PubMed ID: 25737085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discovery of potential LXRβ agonists from Chinese herbs using molecular simulation methods].
    Luo GG; Lu F; Qiao LS; Li Y; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3065-3071. PubMed ID: 28920350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acid receptor agonists.
    Boatman PD; Richman JG; Semple G
    J Med Chem; 2008 Dec; 51(24):7653-62. PubMed ID: 18983141
    [No Abstract]   [Full Text] [Related]  

  • 13. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
    van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
    J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
    Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
    Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid receptor subtypes and their ligands.
    Soudijn W; van Wijngaarden I; Ijzerman AP
    Med Res Rev; 2007 May; 27(3):417-33. PubMed ID: 17238156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-expression β(1) adrenergic receptor/cell membrane chromatography method based on a target receptor to screen active ingredients from traditional Chinese medicines.
    Yue Y; Xue H; Wang X; Yang Q; Song Y; Li X
    J Sep Sci; 2014 Feb; 37(3):244-9. PubMed ID: 24272943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy.
    Sucher NJ
    Epilepsy Behav; 2006 Mar; 8(2):350-62. PubMed ID: 16455305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on anti-hyperlipidemia mechanism of high frequency herb pairs by molecular docking method].
    Jiang LD; He YS; Chen X; Tao O; Li GY; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(12):2413-9. PubMed ID: 26591535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.